NORA also addressed the broadly recognized need to focus research in the areas with the highest likelihood of reducing the still significant toll of workplace illness and injury. Each day, an average of 9,000 U.S. workers sustain disabling injuries on the job, 16 workers die from an injury sustained at work, and 137 workers die from work-related diseases.
The economic burden of this continuing toll is high. Data from a NIOSH-funded study published in 1997 showed that in 1992, direct and indirect costs of occupational injuries and illnesses totaled $171 billion ($145 billion for injuries and $26 billion for diseases). These costs compare to $33 billion for AIDS, $67.3 billion for Alzheimer's Disease, $164.3 billion for circulatory diseases, and $170.7 billion for cancer (see graphic below).
Developing NORA was only the first step in the collaborative effort between NIOSH and its many partners to guide and promote occupational safety and health research. Even at the time the Agenda was announced, there was a common commitment to work to implement the Agenda, namely, to increase activities and resources in the 21 priority areas.
In the first three years of the implementation of NORA, NIOSH and its partners have demonstrated that NORA is generating funding and research activities in the 21 priority areas. The 20 partnership teams (the two musculoskeletal priority research areas are being addressed by one team) have been instrumental in this success.
Prior to NORA, research in occupational safety and health was fragmented, suffering from a "shotgun" approach to tackling major problems. Through NORA, we hope to better position the Nation to address the toll of workplace injury and death.
This page was last updated: May 24, 1999
